Spontaneous regression is a well observed phenomenon in RCC and therefore, immune modulating agents like Interferon (IFN) and Interleukin-2 (IL-2) were commonly used treatments before the advent of TKIs [5,6,7]. The gene discussed is IL2; the disease is renal cell adenocarcinoma.